GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Lux Health Tech Acquisition Corp (NAS:LUXAU) » Definitions » Price-to-Owner-Earnings

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Price-to-Owner-Earnings : (As of Jun. 03, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Lux Health Tech Acquisition Price-to-Owner-Earnings?

As of today (2024-06-03), Lux Health Tech Acquisition's share price is $10.0245. Lux Health Tech Acquisition does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Lux Health Tech Acquisition's Price-to-Owner-Earnings or its related term are showing as below:


LUXAU's Price-to-Owner-Earnings is not ranked *
in the Diversified Financial Services industry.
Industry Median: 6.325
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-03), Lux Health Tech Acquisition's share price is $10.0245. Lux Health Tech Acquisition's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $0.00. Therefore, Lux Health Tech Acquisition's PE Ratio for today is N/A.

As of today (2024-06-03), Lux Health Tech Acquisition's share price is $10.0245. Lux Health Tech Acquisition's EPS without NRI for the trailing twelve months (TTM) ended in was $0.00. Therefore, Lux Health Tech Acquisition's PE Ratio without NRI for today is N/A.

During the past 2 years, Lux Health Tech Acquisition's highest PE Ratio without NRI was 22.85. The lowest was 0.00. And the median was 0.00.


Lux Health Tech Acquisition Price-to-Owner-Earnings Historical Data

The historical data trend for Lux Health Tech Acquisition's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lux Health Tech Acquisition Price-to-Owner-Earnings Chart

Lux Health Tech Acquisition Annual Data
Trend Dec20 Dec21
Price-to-Owner-Earnings
- -

Lux Health Tech Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - -

Competitive Comparison of Lux Health Tech Acquisition's Price-to-Owner-Earnings

For the Shell Companies subindustry, Lux Health Tech Acquisition's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lux Health Tech Acquisition's Price-to-Owner-Earnings Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Lux Health Tech Acquisition's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Lux Health Tech Acquisition's Price-to-Owner-Earnings falls into.



Lux Health Tech Acquisition Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Lux Health Tech Acquisition's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=10.0245/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lux Health Tech Acquisition  (NAS:LUXAU) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Lux Health Tech Acquisition Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Lux Health Tech Acquisition's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Lux Health Tech Acquisition (Lux Health Tech Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
920 Broadway, 11th Floor, New York, NY, USA, 10010
Lux Health Tech Acquisition Corp is a blank check company.
Executives
Frederic H Moll director C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
Joshua Defonzo director, officer: Chief Executive Officer 1500 CORDILLERAS AVENUE, SAN CARLOS CA 94070
Peter Hebert director, 10 percent owner C/O LUX VENTURES, 295 MADISON AVE, 24TH FLOOR, NEW YORK NY 10017
J Robert Kerrey director NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036
Josh Wolfe 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Bijan Salehizadeh director C/O NAVIMED CAPITAL, 1333 H STREET NW, SUITE 400 WEST, WASHINGTON DC 20005
Segolene Scarborough officer: CFO and Treasurer C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Sponsor, Lp 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Holdings, Llc 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Headlines